Skip to content
Clinical Trials – home
BelgiumBack to Belgium

Clinical trials in Bornem – page 46

2 138 clinical trials in Bornem, Belgium. Every trial is listed in the EU Clinical Trials Register and updated daily.

Bornem at a glance
2 138
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

2 138 trials in Bornem

Open in trial search

Study on Adding Trastuzumab and Pertuzumab to Treatment for Patients with Resectable HER2 Positive Esophageal Cancer

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Pertuzumab
  • Sponsor:Amsterdam UMC Stichting

Neoplasm+1

Recruiting

Study of NVL-655 for Patients with Advanced Non-Small Cell Lung Cancer and Other Solid Tumors with ALK Mutation

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:NVL-655
  • Sponsor:Nuvalent Inc.

Study on Preventing Hepatic Encephalopathy with Rifaximin and Lactulose in Patients with Alcoholic Liver Cirrhosis Undergoing TIPS Placement

Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years
  • Substances:Lactulose
  • Sponsor:Amsterdam UMC Stichting

Study of Elenestinib for Patients with Indolent Systemic Mastocytosis

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Elenestinib Phosphate
  • Sponsor:Blueprint Medicines Corp.

Lymphoma+4

Recruiting

Study of OSE-279 and OSE2101 Drug Combination for Patients with Advanced Solid Tumors, Lymphomas, or Metastatic Non-Small Cell Lung Cancer

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Imsidolimab
  • Sponsor:OSE Immunotherapeutics

Medulloblastoma

Recruiting

Study of drug combination therapy for high-risk medulloblastoma in patients over 3 years of age: carboplatin, cisplatin, cyclophosphamide, lomustine, temozolomide, thiotepa, vincristine

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Carboplatin
  • Sponsor:The University Of Birmingham

Study of amoxicillin-clavulanic acid, piperacillin-tazobactam and meropenem dosing in critically ill children with systemic infections

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Amoxicillin Sodium
  • Sponsor:Universitair Ziekenhuis Gent

Study on Adding Atezolizumab and WT1/DC Vaccine to Standard Treatment for Patients with Epithelioid Malignant Pleural Mesothelioma

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:Antwerp University Hospital

Study on STC-1010 and Drug Combination for Patients with Advanced or Metastatic Colorectal Cancer

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Calcium Folinate
  • Sponsor:Brenus Pharma

Study on Doxapram for Treating Apnea in Preterm Newborns

Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Doxapram Hydrochloride Monohydrate
  • Sponsor:Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Study on Treating Chronic Lymphocytic Leukemia with Venetoclax and Acalabrutinib for Patients Whose Disease Has Returned After Initial Treatment

InvestigationalNo placebo
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Acalabrutinib
  • Sponsor:Hemato-Oncologie voor Volwassenen Nederland (Hovon) Stichting

Study on Treating Acute Myeloid Leukemia in Children and Adolescents Using Daunorubicin, Mitoxantrone, and a Drug Combination

Registered drugNo placebo
Countries:BelgiumBelgium
  • Participants:0–17 years · 18–64 years
  • Substances:Cytarabine
  • Sponsor:Vastra Gotalandsregionen

Other cities in Belgium

The busiest research cities in the country

All 164 cities in Belgium

Clinical research in Bornem

What the registry says about research in the country

01 Oncology Research

Innovative clinical trials focusing on colon cancer treatment and survival outcomes. Research explores the potential benefits of common medications in cancer recurrence prevention.

  • Cancer Survival Studies
  • Preventive Medicine
  • Post-Surgery Care

The study examines how acetylsalicylic acid therapy might improve long-term survival rates for patients who have undergone colon cancer surgery, specifically targeting stage II and III cases.

02 Preventive Medicine

Investigation into the role of daily aspirin therapy in preventing cancer recurrence, representing an innovative approach to post-operative care in oncology.

  • Long-term Patient Care
  • Drug Repurposing
  • Cancer Prevention

This research explores how commonly available medications might be repurposed to enhance cancer treatment outcomes and improve patient survival rates.

03 Surgical Oncology

Studies focusing on patients with resected colon carcinoma, examining post-surgical interventions that may enhance treatment success.

  • Post-Operative Care
  • Cancer Recovery
  • Treatment Optimization

Research aimed at developing comprehensive treatment strategies that combine surgical intervention with long-term preventive measures.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.